Latest schizophrenia Stories
The Firm is representing numerous clients in Risperdal lawsuits that allege gynecomastia, or male breast development, due to their use of the antipsychotic drug. New
Schizophrenia affects about one percent of the world’s population and, if untreated, leaves sufferers struggling with their relationships, jobs, and lives as a whole.
First Patient Dosed in the EU Post-Authorization Safety Study MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc.
Risperdal Lawsuit Claims Continue to Be Filed Against Johnson & Johnson Contending Male Breast Growth Due to the Manufacturer’s Antipsychotic Drug Risperdal Reports Wright & Schulte
The Firm is representing Risperdal lawsuit clients who allegedly developed gynecomastia, or male breast growth, due to the use of the antipsychotic medication. New
First ADASUVE Launch in Latin America MOUNTAIN VIEW, Calif., Aug. 8, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc.
Promotes Knowledge of Brain Disorders and Encourages Anti-Stigma Efforts TITUSVILLE, N.J., Aug.
A specific electrical pattern has been identified in the brains of genetically identical mice which accurately predicts how well individual animals will fare in stressful situations, according to new research by Duke University scientists.
The Firm is currently representing clients in Risperdal lawsuits that similarly allege the atypical antipsychotic medication caused gynecomastia, a condition categorized by male breast development.
The largest genomic dragnet of any psychiatric disorder to date has unmasked 108 chromosomal sites harboring inherited variations in the genetic code linked to schizophrenia, 83 of which had not been previously reported.